NCT01662362View on ClinicalTrials.gov

Abbott ESA Chagas Assay Post-Market Study

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Chagas Disease
Interventions
DEVICE

Testing Donor Specimens with ESA Chagas

Donors will be asked to return for a follow-up blood draw.

Trial Locations (2)

20877

American Red Cross, Gaithersburg

60018

LifeSource, Rosemont

All Listed Sponsors
lead

Abbott Diagnostics Division

INDUSTRY

NCT01662362 - Abbott ESA Chagas Assay Post-Market Study | Biotech Hunter | Biotech Hunter